LabCorp (NYSE:LH) processed more tests in the fourth quarter than it did same period in the prior year but it made less money per test and the laboratory testing and diagnostics firm's revenue and earnings results fell short of analyst estimates.
Updated January 13
LabCorp is among the first laboratories offering NanoString Technologies' prognostic breast cancer test, which has been shown in studies to offer better information compared to existing cancer assays.
December 5, 2013
Myriad Genetics, the company that went all the way to the U.S. Supreme Court seeking patents on human genes, now claims LabCorp's new genetic tests for breast cancer infringe on its patents. Read more about the suit.
October 29, 2013
Garheng Kong, a former partner at venture capital firm Intersouth Partners in Durham, is the newest member of the board at lab testing giant LabCorp.
October 18, 2013
After 17 years at LabCorp, CFO Brad Hayes plans to retire from the laboratory testing and diagnostics company next year.
August 8, 2013
The layoffs affect workers at LabCorp locations in Irvine, Calif. and Los Angeles.
July 19, 2013
Despite posting revenue gains, LabCorp's profit was hurt by rising costs.
April 19, 2013
LabCorp said that margins were negatively affected by weather, Medicare payment reductions and the number of days in the quarter.
Updated April 2, 2013
The lab testing giant signs a contract for services and biomarker testing with Bristol-Myers Squibb. LabCorp also says it is expanding tests related to inflammatory bowel disease.
February 8, 2013
LabCorp, the lab testing giant, said Friday it is launching a $1 billion share buyback program.
October 12, 2012
Thomas Mac Mahon, chief executive officer at LabCorp for a decade who then became the firm;s chairman, is retiring from the board of directors.
August 21, 2012
The lab testing firm, which earlier this month was the subject of leveraged buyout rumors on Wall Street, is selling bonds in two $500 million packages.
Updated August 2, 2012
The lab testing firm, which is based in Burlington, says it is "aware" of possible buyout talk but says it's "not in current discussions."
July 19, 2012
June 5, 2012
The Burlington-based company's latest deal - $241 million for Medtox Scientific - is just the latest in a series of acquisitions made over the past three years.
Timeline tracks LabCorp's history, growth
June 4, 2012
Burlington-based Laboratory Corporation of America agrees to buy Medtox Scientific in an all-cash deal worth $241 million.
May 24, 2012
Burlington-based LabCorp will work with XDx to develop a biomarker and commercialize a test for the flares -- extended periods of activity for the autoimmune disease. Lupus causes the body's immune system to attack its own tissues, which leads to inflammation and organ damage.
April 5, 2012
Alzheimer's disease affects more than five million people in the United States and more than 35 million worldwide. There are no specific tests available to detect Alzheimer's disease and track its progression. Diagnosis is currently conducted by behavioral and cognitive measurements.
Updated February 13, 2012
Alien Skin's latest software; SciQuest lands new customer; DadaFlux launches "Learning Café;" LabCorp revenue climbs; Verizon's 4G plans in NC.
December 22, 2011
LabCorp said it has set $1 billion in credit in an arrangement with Bank of America.